Institutional investors purchased a net $1.9 million shares of GSK during the quarter ended March 2016 and now own 9.09% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLER/HOWARD INVESTMENTS, INC. Bought 614.0 Thousand shares of GlaxoSmithKline
HONEYWELL CAPITAL MANAGEMENT LLC Bought 450.0 Thousand shares of GlaxoSmithKline
T. ROWE PRICE INTERNATIONAL LTD. Bought 264.5 Thousand shares of GlaxoSmithKline